Changes in arginase isoforms in a murine model of neonatal brain hypoxia-ischemia.
Animals
Animals, Newborn
Arginase
/ biosynthesis
Brain
/ metabolism
Brain Injuries
/ pathology
Cerebral Cortex
/ metabolism
Disease Models, Animal
Female
Hippocampus
/ metabolism
Hypoxia
/ pathology
Hypoxia-Ischemia, Brain
/ pathology
Immunohistochemistry
Inflammation
/ pathology
Male
Mice
Mice, Inbred C57BL
Microglia
/ metabolism
Neuroinflammatory Diseases
Neurons
/ metabolism
Protein Isoforms
Journal
Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
06
11
2019
accepted:
12
05
2020
revised:
27
04
2020
pubmed:
29
5
2020
medline:
15
1
2022
entrez:
29
5
2020
Statut:
ppublish
Résumé
Arginases (ARG isoforms, ARG-1/ARG-2) are key regulatory enzymes of inflammation and tissue repair; however, their role after neonatal brain hypoxia (H) and hypoxia-ischemia (HI) remains unknown. C57BL/6 mice subjected to the Vannucci procedure on postnatal day (P9) were sacrificed at different timepoints. The degree of brain damage was assessed histologically. ARG spatiotemporal localization was determined via immunohistochemistry. ARG expression was measured by Western blot and activity spectrophotometrically. ARG isoform expression increased during neurodevelopment (P9-P17) in the cortex and hippocampus. This was suppressed with H and HI only in the hippocampus. In the cortex, both isoforms increased with H alone and only ARG-2 increased with HI at 3 days. ARG activity during neurodevelopment remained unchanged, but increased at 1 day with H and not HI. ARG-1 localized with microglia at the injury site as early as 4 h after injury, while ARG-2 localized with neurons. ARG isoform expression increases with age from P9 to P17, but is suppressed by injury specifically in the hippocampus and not in the cortex. Both levels and activity of ARG isoforms increase with H, while ARG-1 immunolabelling is upregulated in the HI cortex. Evidently, ARG isoforms in the brain differ in spatiotemporal localization, expression, and activity during neurodevelopment and after injury. Arginase isoforms change during neurodevelopment and after neonatal brain HI. This is the first study investigating the key enzymes of inflammation and tissue repair called arginases following murine neonatal brain HI. The highly region- and cell-specific expression suggests the possibility of specific functions of arginases. ARG-1 in microglia at the injury site may regulate neuroinflammation, while ARG-2 in neurons of developmental structures may impact neurodevelopment. While further studies are needed to describe the exact role of ARGs after neonatal brain HI, our study adds valuable data on anatomical localization and expression of ARGs in brain during development and after stroke.
Sections du résumé
BACKGROUND
Arginases (ARG isoforms, ARG-1/ARG-2) are key regulatory enzymes of inflammation and tissue repair; however, their role after neonatal brain hypoxia (H) and hypoxia-ischemia (HI) remains unknown.
METHODS
C57BL/6 mice subjected to the Vannucci procedure on postnatal day (P9) were sacrificed at different timepoints. The degree of brain damage was assessed histologically. ARG spatiotemporal localization was determined via immunohistochemistry. ARG expression was measured by Western blot and activity spectrophotometrically.
RESULTS
ARG isoform expression increased during neurodevelopment (P9-P17) in the cortex and hippocampus. This was suppressed with H and HI only in the hippocampus. In the cortex, both isoforms increased with H alone and only ARG-2 increased with HI at 3 days. ARG activity during neurodevelopment remained unchanged, but increased at 1 day with H and not HI. ARG-1 localized with microglia at the injury site as early as 4 h after injury, while ARG-2 localized with neurons.
CONCLUSIONS
ARG isoform expression increases with age from P9 to P17, but is suppressed by injury specifically in the hippocampus and not in the cortex. Both levels and activity of ARG isoforms increase with H, while ARG-1 immunolabelling is upregulated in the HI cortex. Evidently, ARG isoforms in the brain differ in spatiotemporal localization, expression, and activity during neurodevelopment and after injury.
IMPACT
Arginase isoforms change during neurodevelopment and after neonatal brain HI. This is the first study investigating the key enzymes of inflammation and tissue repair called arginases following murine neonatal brain HI. The highly region- and cell-specific expression suggests the possibility of specific functions of arginases. ARG-1 in microglia at the injury site may regulate neuroinflammation, while ARG-2 in neurons of developmental structures may impact neurodevelopment. While further studies are needed to describe the exact role of ARGs after neonatal brain HI, our study adds valuable data on anatomical localization and expression of ARGs in brain during development and after stroke.
Identifiants
pubmed: 32464635
doi: 10.1038/s41390-020-0978-3
pii: 10.1038/s41390-020-0978-3
pmc: PMC7704631
mid: NIHMS1596129
doi:
Substances chimiques
Protein Isoforms
0
Arginase
EC 3.5.3.1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
830-837Subventions
Organisme : NINDS NIH HHS
ID : R35 NS097299
Pays : United States
Références
Neurobiol Aging. 2004 Apr;25(4):547-52
pubmed: 15013576
Am J Physiol Endocrinol Metab. 2001 Jan;280(1):E75-82
pubmed: 11120661
Mech Dev. 2002 Jul;115(1-2):151-5
pubmed: 12049781
Int J Biochem. 1983;15(8):1081-4
pubmed: 6617953
Cell Death Dis. 2016 Nov 24;7(11):e2483
pubmed: 27882947
Neurochem Res. 2019 Jun;44(6):1306-1322
pubmed: 30357653
Front Cell Neurosci. 2016 Dec 15;10:286
pubmed: 28018179
Biochem Med Metab Biol. 1986 Apr;35(2):156-69
pubmed: 3707749
Hippocampus. 2003;13(7):859-67
pubmed: 14620881
Neuron. 2002 Aug 15;35(4):711-9
pubmed: 12194870
Eur J Neurosci. 2013 Apr;37(7):1193-202
pubmed: 23311438
Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):E11293-E11302
pubmed: 29229845
Handb Clin Neurol. 2019;162:239-266
pubmed: 31324313
Dev Neurosci. 2018;40(5-6):437-450
pubmed: 30995639
Cortex. 2015 Jan;62:34-40
pubmed: 25091482
Neuroscience. 2003;119(3):679-87
pubmed: 12809689
Immunity. 2019 Jan 15;50(1):253-271.e6
pubmed: 30471926
Acta Histochem. 2012 Sep;114(5):487-94
pubmed: 21975054
Biochem J. 1998 Nov 15;336 ( Pt 1):1-17
pubmed: 9806879
Pediatr Res. 2006 May;59(5):680-3
pubmed: 16627881
Glia. 2017 Jul;65(7):1152-1175
pubmed: 28456012
J Neurotrauma. 2017 Jan 1;34(1):192-203
pubmed: 26757855
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4194-9
pubmed: 17360499
J Cereb Blood Flow Metab. 2005 Dec;25(12):1586-95
pubmed: 15917746
J Neuroinflammation. 2014 Jun 03;11:98
pubmed: 24889886
J Neurosci Res. 2001 Nov 1;66(3):406-22
pubmed: 11746358
Transl Stroke Res. 2016 Apr;7(2):103-10
pubmed: 26515089
J Neurosci. 2006 Aug 16;26(33):8512-6
pubmed: 16914676
Brain Res. 2012 May 9;1453:77-86
pubmed: 22483960
Yonsei Med J. 2016 Nov;57(6):1329-38
pubmed: 27593859
J Neurosci Res. 2013 Sep;91(9):1143-51
pubmed: 23686747
Nat Rev Neurosci. 2007 Apr;8(4):287-99
pubmed: 17375041
Brain Res Bull. 1984 Jun;12(6):657-68
pubmed: 6206929
Front Neurol. 2015 Apr 08;6:81
pubmed: 25904895
Biomaterials. 2016 Jun;91:151-165
pubmed: 27031810
J Neurosci. 2009 Jul 29;29(30):9545-52
pubmed: 19641117